The document discusses how product dossiers are used by health care decision makers and where opportunities exist to improve them. It notes challenges with traditional dossiers and reviews AMCP's eDossier system. The presentation aims to examine which dossier sections are most valuable, what additional resources payers find useful, and how the value of dossiers can be further supported. It encourages manufacturers to get involved in the eDossier system.
1 of 13
More Related Content
Ppt Cahill
1. Understanding the Payer
How Dossiers are Used in Real-World Decision Making and
Where Opportunities Exist for Filling in the Gaps
Judy Cahill
Executive Director
Academy of Managed Care Pharmacy
2nd Annual Health Outcomes and Pharmacoeconomics Conference
February 2, 2011
Objectives
2. Review how innovative technology can increase the
usefulness and application of evidence presented in
product dossiers
Challenges with traditional dossiers
5. Feedback from participating manufacturers
Examine which sections of product dossiers are most
utilized and valued by decision makers
6. Value of product dossiers to HCDMs
Standard dossier sections (AMCP Format v3.0)
7. Value/Usefulness of sections within product dossiers
(1=Not of Value/Not Useful; 5=Very Valuable/Very Useful)
Sections most often accessed
Percent of hits for a sample of active product eDossiers
8. Understand what resources payers believe may
complement dossiers & support evidence-based
decision making
Payer feedback: Various tools and resources considered
useful by decision makers
(A) Electronic (C) Data analysis tools
(B) Online Budget for use with health (I) Education tools
Dossier Tools Impact Models
plans claims data
Dymaxium Inc. Health Care Decision Maker Focus Group. San Diego, CA. April 2007.
9. Payer feedback: Scientific resources that complement
dossiers in the decision making process
How can the value of dossiers be further supported?